The relationship between cancer incidence, stage and poverty in the United States

International Journal of Cancer

Volumn 139, Issue 3, 2016, Pages 607-612

  Boscoe, Francis P ^a   Henry, Kevin A ^b,c   Sherman, Recinda L ^d   Johnson, Christopher J ^e  

^a NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^b TEMPLE UNIVERSITY   (United States)

^c FOX CHASE CANCER CENTER   (United States)

^d North American Association of Central Cancer Registries   (United States)

^e Cancer Data Registry of Idaho   (United States)

Author keywords

cancer incidence; disparities; socioeconomic status

Indexed keywords

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER SCREENING; CANCER STAGING; DISEASE ASSOCIATION; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH DISPARITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; POVERTY; PRIORITY JOURNAL; PROSTATE CANCER; SOCIAL STATUS; UNITED STATES; INCIDENCE; NEOPLASMS; ODDS RATIO; PATHOLOGY; REGISTER;

FEMALE; HUMANS; INCIDENCE; MALE; NEOPLASM STAGING; NEOPLASMS; ODDS RATIO; POVERTY; REGISTRIES; UNITED STATES;

EID: 84963568202     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.30087     Document Type: Article

References (26)

1. Ward E, Jemal A, Cokkinides V, et al., Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin 2004; 54: 78-93.
2. Bryere J, Dejardin O, Bouvier V, et al., Socioeconomic environment and cancer incidence: a French population-based study in Normandy. BMC Cancer 2014; 14: 87.
3. Boscoe FP, Johnson CJ, Sherman RL, et al., The relationship between area poverty rate and site-specific cancer incidence in the United States. Cancer 2014; 120: 2191-8.
4. Rimpelä AH, Pukkala EI., Cancers of affluence: positive social class gradient and rising incidence trend in some cancer forms. Soc Sci Med 1987; 24: 601-6.
5. Abe T, Martin IB, Roche LM., Clusters of census tracts with high proportions of men with distant-stage prostate cancer incidence in New Jersey, 1995 to 1999. Am J Prev Med 2006; 30: S60-S66.
6. Harper S, Lynch J., Methods for measuring cancer disparities: using data relevant to healthy people 2010 cancer-related objectives. NCI Cancer Surveillance Monograph Series, Number 6. Bethesda, MD: National Cancer Institute, 2005.
7. Harper S, Lynch J., Selected comparisons of measures of health disparities: a review using databases relevant to Healthy People 2010 cancer-related objectives. NCI Cancer Surveillance Monograph Series, Number 7. Bethesda, MD: National Cancer Institute, 2007.
8. Moser K, Frost C, Leon DA., Comparing health inequalities across time and place-rate ratios and rate differences lead to different conclusions: analysis of cross-sectional data from 22 countries 1991-2001. Int J Epidemiol 2007; 36: 1285-91.
9. Regidor E, Sánchez E, de La Fuente L, et al., Major reduction in AIDS-mortality inequalities after HAART: the importance of absolute differences in evaluating interventions. Soc Sci Med 2009; 68: 419-26.
10. King NB, Harper S, Young ME., Use of relative and absolute effect measures in reporting health inequalities: structured review. BMJ 2012; 345: e5774.
11. North American Association of Central Cancer Registries. CINA Deluxe Analytic File 2016. Available at: http://www.naaccr.org/research/cinadeluxe.aspx, accessed on February 3, 2016.
12. Singh GK, Miller BA, Hankey BF, et al., Area socioeconomic variations in U.S. cancer incidence, mortality, stage, treatment, and survival, 1975-1999. NCI Cancer Surveillance Monograph Series, Number 4. Bethesda, MD: National Cancer Institute, 2003.
13. Krieger N, Chen JT, Waterman PD, et al., Race/ethnicity, gender, and monitoring socioeconomic gradients in health: a comparison of area-based socioeconomic measures-the public health disparities geocoding project. Am J Public Health 2003; 93: 1655-71.
14. Freedman M., Teaching new markets old tricks: the effects of subsidized investment on low-income neighborhoods. J Public Econ 2012; 96: 1000-14.
15. National Cancer Institute, Surveillance, Epidemiology, and End Results Program. Site recode ICD-O-3/WHO 2008 definition 2015. Available at: http://seer.cancer.gov/siterecode/icdo3-dwhoheme/index.html, accessed on September 11, 2015.
16. Young JL, Jr, Roffers SD, Ries LAG, et al., eds. SEER summary staging manual-2000: codes and coding instructions. Bethesda, MD: National Cancer Institute, 2001.
17. Henry KA, Sherman RL, McDonald K, et al., Associations of census tract poverty with subsite-specific colorectal cancer incidence rates and stage of disease at diagnosis in the United States. J Cancer Epidemiol 2014; 823484.
18. Boscoe FP, Henry KA, Sherman RL, et al., Fileset for "The relationship between cancer incidence, stage, and poverty in the United States". 2015. Available at: http://dx.doi.org/10.6084/m9.figshare.1539609, accessed on September 11, 2015.
19. Plutynski A., Ethical issues in cancer screening and prevention. J Med Philos 2012; 37: 310-23.
20. National Cancer Institute. SEER Cancer Statistics Factsheets: Prostate Cancer. 2015. Available at: http://seer.cancer.gov/statfacts/html/prost.html, accessed on September 11, 2015.
21. National Cancer Institute. SEER Cancer Statistics Factsheets: Breast Cancer. 2015. Available at: http://seer.cancer.gov/statfacts/html/breast.html, accessed on September 11, 2015.
22. National Cancer Institute. SEER Cancer Statistics Factsheets: Lung and Bronchus Cancer. 2015. Available at: http://seer.cancer.gov/statfacts/html/lungb.html, accessed on September 11, 2015.
23. Singh GK, Williams SD, Siahpush M, et al., Socioeconomic, rural-urban, and racial inequalities in US cancer mortality: part I-all cancers and lung cancer and part II-colorectal, prostate, breast, and cervical cancers. J Cancer Epidemiol 2011; 107497.
24. Welch HG, Black WC., Overdiagnosis in cancer. J Natl Cancer Inst 2010; 102: 605-13.
25. Moyer VA,; U.S. Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2012; 157: 120-34.
26. Scarinci IC, Garcia FAR, Kobetz E, et al., Cervical cancer prevention: new tools and old barriers. Cancer 2010; 116: 2531-42.